However, we previously found that the expression of GluA3 is necessary for Aβ to trigger synaptic impairments, since neurons are fully resistant to Aβ-mediated synaptic depression when they lack GluA3 (Reinders et al., 2016). The gene discussed is GRIA3; the disease is depressive symptom measurement.